Table_2_The Use of Defatted Tenebrio molitor Larvae Meal as a Main Protein Source Is Supported in European Sea Bass (Dicentrarchus labrax) by Data on Growth Performance, Lipid Meta... by Ana Basto (10650053)

“…The expression of cholesterol 7 alpha-monooxygenase (cyp7a1) decreased with dietary dTM inclusion. In muscle, the expression of myoblast determination protein-2 (myod2) decreased in fish fed TM80 and TM100.…”

Table_1_The Use of Defatted Tenebrio molitor Larvae Meal as a Main Protein Source Is Supported in European Sea Bass (Dicentrarchus labrax) by Data on Growth Performance, Lipid Meta... by Ana Basto (10650053)

“…The expression of cholesterol 7 alpha-monooxygenase (cyp7a1) decreased with dietary dTM inclusion. In muscle, the expression of myoblast determination protein-2 (myod2) decreased in fish fed TM80 and TM100.…”

Table_2_The Use of Defatted Tenebrio molitor Larvae Meal as a Main Protein Source Is Supported in European Sea Bass (Dicentrarchus labrax) by Data on Growth Performance, Lipid Meta... by Ana Basto (10650053)

“…The expression of cholesterol 7 alpha-monooxygenase (cyp7a1) decreased with dietary dTM inclusion. In muscle, the expression of myoblast determination protein-2 (myod2) decreased in fish fed TM80 and TM100.…”

Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellu... by Chitra Dhanasekar (841574)

“…For comparison purpose, colchicine was used as a reference drug. We have observed that morin (100–300 μM) treatment significantly suppressed the levels of inflammatory cytokines (TNF-α, IL-1β, IL-6, MCP-1 and VEGF), inflammatory mediators (NO and PEG₂), and lysosomal enzymes (acid phosphatase, β-galactosidase, N-acetyl glucosamindase and cathepsin D) in MSU-crystals stimulated macrophage cells. …”

Export flux succession of dinoflagellate cysts and planktonic foraminifera in an active upwelling cell off Cape Blanc (NW Africa) by Karin A.F. Zonneveld (10777280)

“…<p>To better understand production, succession, excystment and transport of dinoflagellate cysts (dinocysts) and planktonic foraminifera in the upper water column, we investigated their fluxes during a 7-day survey in the active upwelling off Cape Blanc (NW Africa) in November 2018 with drifting traps at 100 m, 200 m and 400 m water depth. …”

Antimicrobial resistance profiles of <i>Salmonella</i> Typhimurium isolates from rats and humans (blood cultures). by Dadi Falay (3469562)

Data Sheet 1_Global, regional, and national burden of sudden infant death syndrome, 1990–2021: a comprehensive analysis of GBD 2021 data with insights into the impact during the CO... by Yuhan Sun (299077)

“…Global DALYs were 2,746,174, at a rate of 2,167.56 per 100,000 infants (95% UI, 1,261.44–2,909.59). …”

DataSheet_1_Efficacy and safety of anlotinib plus XELOX regimen as first-line therapy for mCRC: a single-arm, multicenter, phase II study (ALTER-C-001).docx by Bo Song (255492)

Data_Sheet_1_Association of high-estimated glomerular filtration rate with the severity of ischemic stroke during non-vitamin K antagonist oral anticoagulants therapy: a nationwide... by Min Kyoung Kang (3829759)

“…The eGFR of 60 to 89 mL/min/1.73 m² group was associated with a decreased risk of moderate-to-severe stroke severity [hazard ratio (HR)] (0.77, 95% confidence interval (CI) [0.61, 0.98], p = 0.031) compared to the eGFR≥90 mL/min/1.73 m² group. …”

Data Sheet 1_Excess mortality in young cancer survivors compared with the general population in Italy: a retrospective study from the Italian population-based cohort of adolescents... by Paolo Giorgi Rossi (9311547)

“…Young adult cancer survivors face a sevenfold increase in all-cause mortality compared to the general population, with a notable rise in both cancer-related and non-cancer deaths. …”

Table_1_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patien... by Minghui Li (409892)

“…HBsAg disappearance rate was the primary evaluation index at 48 weeks of PEG-IFN treatment.</p>Results<p>Among 100 patients who completed the 48-week PEG-IFN α-2a treatment, 38 patients achieved serum HBeAg disappearance, 25 patients achieved HBeAg seroconversion, 9 patients achieved functional cure, 37 patients had HBsAg decline of ≥1 log IU/ml, and 8 patients produced hepatitis B surface antibody (HBsAb). …”

Table_3_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patien... by Minghui Li (409892)

“…HBsAg disappearance rate was the primary evaluation index at 48 weeks of PEG-IFN treatment.</p>Results<p>Among 100 patients who completed the 48-week PEG-IFN α-2a treatment, 38 patients achieved serum HBeAg disappearance, 25 patients achieved HBeAg seroconversion, 9 patients achieved functional cure, 37 patients had HBsAg decline of ≥1 log IU/ml, and 8 patients produced hepatitis B surface antibody (HBsAb). …”

Table_2_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patien... by Minghui Li (409892)

“…HBsAg disappearance rate was the primary evaluation index at 48 weeks of PEG-IFN treatment.</p>Results<p>Among 100 patients who completed the 48-week PEG-IFN α-2a treatment, 38 patients achieved serum HBeAg disappearance, 25 patients achieved HBeAg seroconversion, 9 patients achieved functional cure, 37 patients had HBsAg decline of ≥1 log IU/ml, and 8 patients produced hepatitis B surface antibody (HBsAb). …”

Supplementary file 1_The evolution of the global disease burden of polycystic ovary syndrome and the role of regional heterogeneity in high body mass index exposure: a spatiotempor... by Ying Feng (151159)

“…</p>Results<p>In 2021, the global age-standardized prevalence rate (ASPR) of PCOS was 867.7 per 100,000 [95% UI: 618.7–1,195.3], representing a significant increase of 0.75 compared with 1990 [95% CI: 0.71–0.78]. …”

Stimulus protocols. by Penelope A. McNulty (441014)

“…Self-sustained activity was evident in the right wrist extensors with both stimulus patterns, but not in the right thenar muscles. A: 25 Hz for 2 s then 100 Hz for 2 s then 25 Hz for 3 s, C: ramp stimulus, increasing from 1 Hz to 100 Hz over 5 s and then decreasing to 1 Hz over 5 s.…”

Gene expression of <i>Vegf-A</i> and <i>Mcp-1</i> by qRT-PCR at the outflow vein of AVF three days after fistula placement in <i>Iex-1</i> KO and WT mice. by Akshaar Brahmbhatt (551498)

“…There is a significant decrease in the average gene expression of <i>Vegf-A</i> in the <i>Iex-1</i> KO animals when compared to WT controls (P<0.05). …”

Crystal size distributions. by Guilherme A. R. Gualda (161367)

“…(c) 3D view of pumice chip (sample AB-6203F), showing euhedral quartz and feldspar grains (green), magnetite (blue), and pyroxene±biotite (white); notice the overall trend of decreasing numbers of crystals with increasing size; sample is approximately cylindrical, field of view ∼9 mm (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0037492#pone.0037492.s001" target="_blank">Movie S1</a> for animated version). …”

DataSheet1_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du... by Joshua R. Tacca (18067213)

“…Furthermore, we found that use of the BiOM with 10% and 20% greater than recommended power increased AL_trail W_pos and decreased UL_lead W_neg magnitude at 0.75–1.00 m/s. …”

DataSheet4_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du... by Joshua R. Tacca (18067213)

“…Furthermore, we found that use of the BiOM with 10% and 20% greater than recommended power increased AL_trail W_pos and decreased UL_lead W_neg magnitude at 0.75–1.00 m/s. …”

DataSheet3_Greater than recommended stiffness and power setting of a stance-phase powered leg prosthesis can improve step-to-step transition work and effective foot length ratio du... by Joshua R. Tacca (18067213)

“…Furthermore, we found that use of the BiOM with 10% and 20% greater than recommended power increased AL_trail W_pos and decreased UL_lead W_neg magnitude at 0.75–1.00 m/s. …”